HBMN:SWX
HBM Healthcare Investments AG
230,00 CHF
0,00%
(0,00) 1 p
28. apr, 17:30:57 GMT +2 · CHF
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse HBMN põhistatistika genereerimine…
Ava
230,00 CHF
Kõrge
231,50 CHF
Madal
228,50 CHF
Turu kapit.
1,55 mld
Keskm. maht
6,52 tuh
Maht
3,11 tuh
Dividend
3,26%
Kvartaalne dividend
1,87 CHF
Dividendikuupäev
2. juuli 2025
Hinna ja tulu suhe
6,40
52 näd kõrgeim
245,50 CHF
52 näd madalaim
157,40 CHF
Aktsiatulu
35,93 CHF
Käibivad aktsiad
6,74 mln
Uudised
Erinevatest veebiallikatest
富途牛牛
·
15 minuti eest
Dow Jones Top Energy Headlines at 12 AM ET: U.A.E.'s OPEC Exit Deals Major Blow to Cartel Amid Middle East Oil Squeeze | UAE ...
富途牛牛
·
15 minuti eest
Dow Jones Top Financial Services Headlines at 12 AM ET: Visa Revenue Climbs as Consumers Keep Spending
MarketBeat
·
26 minuti eest
Short Interest in Intuit Inc. (NASDAQ:INTU) Expands By 36.7%
Simply Wall Street
·
1 tunni eest
A Look At Telesat (NasdaqGS:TSAT) Valuation After Its Strong Recent Share Price Momentum
Profiil
HBM Healthcare Investments is a publicly traded Swiss investment and venture capital firm focusing on emerging technologies in the global healthcare sector. Within healthcare their focus is predominantly in biotechnology, medical technology, diagnostics, therapeutics and digital health.
A 2022 article in Swiss daily Luzerner Zeitung profiled HBM and interviewed its CEO, and described the company’s investment strategy as focused on early-stage but post-seed round opportunities.
Founded in July 2001 as HBM Bioventures AG by former Roche Chief Financial Officer Henri B. Meier who was its first Chairperson of the Board. A Handelszeitung article from 2020 described Meier's goal when founding the company as to profit from the "thesis" that from the 2000s onwards "Big Pharma is doing less and less research and development itself and is instead acquiring promising biotech companies" In an analysis of how HBM was put together, Swiss magazine Finanz und Wirtschaft described how he was able to raise almost 500 million Swiss Francs for the company launch. HBM is based in Zug and managed by HBM Partners. HBM acquired rival Swiss VC International BM Biomedicine in 2005. Wikipedia
Teave üksuse HBM Healthcare Investments AG kohta
Tegevjuht-
Töötajad-
Asutatud12. juuli 2001
PeakontoridZug, Zugi kanton, Šveits
Sektor-
Veebisaithbmhealthcare.com
AI genereeritud sisu võib sisaldada vigu. Lisateave